Free Trial

Xenon Pharmaceuticals (XENE) Insider Trading & Ownership

Xenon Pharmaceuticals logo
$36.44 +0.28 (+0.77%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$36.48 +0.04 (+0.11%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Xenon Pharmaceuticals (NASDAQ:XENE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.91%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$1.68M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$21.97M
Get XENE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xenon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XENE Insider Buying and Selling by Quarter

Xenon Pharmaceuticals Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2026Buy30,000$37.38$1,121,400.00  
9/30/2026
Thomas Patrick Kelly
CFO
Buy15,000$37.32$559,800.00  
8/28/2026Sell7,068$60.25$425,847.00  
8/11/2026Sell10,000$64.06$640,600.00  
6/5/2026
Gary Patou
Director
Sell1,322$53.14$70,251.08  
6/5/2026Sell1,190$53.14$63,236.60  
3/13/2026Sell1,342$55.23$74,118.66  
3/13/2026Sell1,410$55.23$77,874.30  
3/13/2026Sell7,308$55.23$403,620.84  
3/10/2026Sell2,607$60.11$156,706.77  
3/10/2026Sell2,771$60.11$166,564.81  
3/10/2026Sell11,269$60.11$677,379.59  
3/9/2026Sell270,000$60.33$16,289,100.00  
1/2/2026Sell40,000$44.43$1,777,200.00  
12/8/2025Sell10,830$45.73$495,255.90  
12/5/2025Sell14,375$45.03$647,306.25  
11/28/2025Sell97$45.01$4,365.97  
(Data available from 1/1/2013 forward)

XENE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Xenon Pharmaceuticals includes Andrea Difabio, Christopher John Kenney, Gary Patou, Gillian Cannon, Ian Mortimer, Sherrington Robin, Sherry Aulin, Steven Gannon, and Thomas Patrick Kelly. Learn more on insiders at XENE.

2.91% of Xenon Pharmaceuticals stock is owned by insiders. Learn more on XENE's insider holdings.

The following insiders have purchased XENE shares in the last 24 months: Ian Mortimer ($1,121,400.00), and Thomas Patrick Kelly ($559,800.00).

Insiders have purchased a total of 45,000 XENE shares in the last 24 months for a total of $1,681,200.00 bought.

The following insiders have sold XENE shares in the last 24 months: Andrea Difabio ($230,825.43), Christopher John Kenney ($670,286.11), Gary Patou ($271,173.36), Gillian Cannon ($63,236.60), Ian Mortimer ($22,862,199.65), Sherry Aulin ($770,997.89), and Steven Gannon ($640,691.44).

Insiders have sold a total of 468,975 Xenon Pharmaceuticals shares in the last 24 months for a total of $25,509,410.48 sold.



Insider trading data for NASDAQ:XENE was last updated on 9/30/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners